TrialBreast cancer research : BCR2020

Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial.

Signe Korsgaard Skriver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.